Mantle Cell Lymphoma (MCL) Terminated Phase 2 Trials for Fludarabine (DB01073)

Also known as: Lymphoma, Mantle-Cell / Mantle Cell Lymphoma / Mantle-Cell Lymphoma / Lymphoma, Mantle- Cell / Lymphoma, Mantle Cell / Mantle-Cell Lymphomas / B cell lymphoma / Centrocytic lymphoma / Mantle cell lymphoma NOS / Mantle cell lymphomas

IndicationStatusPhase
DBCOND0071979 (Mantle Cell Lymphoma (MCL))Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00183989Combination Therapy With Fludarabine, Mitoxantrone and Rituximab in Mantle Cell LymphomaTreatment
NCT01578343Vorinostat Plus FND in Relapsed or Refractory Mantle Cell LymphomaTreatment